HEADER TRANSFERASE/TRANSFERASE INHIBITOR 03-APR-16 5J5T TITLE GLK CO-CRYSTAL STRUCTURE WITH AMINOPYRROLOPYRIMIDINE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 3; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 13-380; COMPND 5 SYNONYM: GERMINAL CENTER KINASE-RELATED PROTEIN KINASE,GLK,MAPK/ERK COMPND 6 KINASE KINASE KINASE 3,MEKKK 3; COMPND 7 EC: 2.7.11.1; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAP4K3, RAB8IPL1; SOURCE 6 EXPRESSION_SYSTEM: UNIDENTIFIED BACULOVIRUS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 10469 KEYWDS PROTEIN KINSAE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR L.F.SILVIAN,D.MARCOTTE REVDAT 4 03-APR-24 5J5T 1 REMARK REVDAT 3 08-FEB-17 5J5T 1 JRNL REVDAT 2 02-NOV-16 5J5T 1 JRNL REVDAT 1 26-OCT-16 5J5T 0 JRNL AUTH D.MARCOTTE,M.RUSHE,R.M ARDUINI,C.LUKACS,K.ATKINS,X.SUN, JRNL AUTH 2 K.LITTLE,M.CULLIVAN,M.PARAMASIVAM,T.A.PATTERSON,T.HESSON, JRNL AUTH 3 T.D MCKEE,T.L.MAY-DRACKA,Z.XIN,A.BERTOLOTTI-CIARLET, JRNL AUTH 4 G.R.BHISETTI,J.P.LYSSIKATOS,L.F.SILVIAN JRNL TITL GERMINAL-CENTER KINASE-LIKE KINASE CO-CRYSTAL STRUCTURE JRNL TITL 2 REVEALS A SWAPPED ACTIVATION LOOP AND C-TERMINAL EXTENSION. JRNL REF PROTEIN SCI. V. 26 152 2017 JRNL REFN ESSN 1469-896X JRNL PMID 27727493 JRNL DOI 10.1002/PRO.3062 REMARK 2 REMARK 2 RESOLUTION. 2.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.9_1692 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.65 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 7960 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.177 REMARK 3 R VALUE (WORKING SET) : 0.175 REMARK 3 FREE R VALUE : 0.206 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.790 REMARK 3 FREE R VALUE TEST SET COUNT : 381 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 41.6514 - 4.1099 0.99 2539 136 0.1699 0.1813 REMARK 3 2 4.1099 - 3.2625 1.00 2514 134 0.1717 0.2201 REMARK 3 3 3.2625 - 2.8502 1.00 2526 111 0.1936 0.2454 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.230 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 19.340 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 43.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 2418 REMARK 3 ANGLE : 0.676 3277 REMARK 3 CHIRALITY : 0.024 355 REMARK 3 PLANARITY : 0.004 419 REMARK 3 DIHEDRAL : 13.164 878 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5J5T COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-APR-16. REMARK 100 THE DEPOSITION ID IS D_1000219998. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-JUN-15 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 31-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : DIAMOND(111 REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX-225 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 40B0 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.44 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.03 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.8M AMMONIUM SULFATE, 0.1M BISTRIS PH REMARK 280 5.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 46.35150 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 31.66200 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 46.35150 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 31.66200 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4750 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 30510 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -36.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 92.70300 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 11 REMARK 465 LYS A 167 REMARK 465 ARG A 168 REMARK 465 LYS A 169 REMARK 465 ASP A 293 REMARK 465 HIS A 294 REMARK 465 ILE A 315 REMARK 465 HIS A 316 REMARK 465 SER A 317 REMARK 465 THR A 318 REMARK 465 SER A 319 REMARK 465 ARG A 320 REMARK 465 ASN A 321 REMARK 465 VAL A 322 REMARK 465 ARG A 323 REMARK 465 GLU A 324 REMARK 465 GLU A 325 REMARK 465 LYS A 326 REMARK 465 THR A 327 REMARK 465 ARG A 328 REMARK 465 SER A 329 REMARK 465 GLU A 330 REMARK 465 ILE A 331 REMARK 465 THR A 332 REMARK 465 PHE A 333 REMARK 465 GLY A 334 REMARK 465 GLN A 335 REMARK 465 VAL A 336 REMARK 465 LYS A 337 REMARK 465 PHE A 338 REMARK 465 ASP A 339 REMARK 465 PRO A 340 REMARK 465 PRO A 341 REMARK 465 LEU A 342 REMARK 465 ARG A 343 REMARK 465 LYS A 344 REMARK 465 GLU A 345 REMARK 465 THR A 346 REMARK 465 GLU A 347 REMARK 465 PRO A 348 REMARK 465 HIS A 349 REMARK 465 HIS A 350 REMARK 465 GLU A 351 REMARK 465 LEU A 352 REMARK 465 PRO A 353 REMARK 465 ASP A 354 REMARK 465 SER A 355 REMARK 465 ASP A 356 REMARK 465 GLY A 357 REMARK 465 PHE A 358 REMARK 465 LEU A 359 REMARK 465 ASP A 360 REMARK 465 SER A 361 REMARK 465 SER A 362 REMARK 465 GLU A 363 REMARK 465 GLU A 364 REMARK 465 ILE A 365 REMARK 465 TYR A 366 REMARK 465 TYR A 367 REMARK 465 THR A 368 REMARK 465 ALA A 369 REMARK 465 ARG A 370 REMARK 465 SER A 371 REMARK 465 ASN A 372 REMARK 465 LEU A 373 REMARK 465 ASP A 374 REMARK 465 LEU A 375 REMARK 465 GLN A 376 REMARK 465 LEU A 377 REMARK 465 GLU A 378 REMARK 465 TYR A 379 REMARK 465 GLY A 380 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 14 CG CD OE1 OE2 REMARK 470 GLU A 17 CG CD OE1 OE2 REMARK 470 ASP A 84 CB CG OD1 OD2 REMARK 470 SER A 97 OG REMARK 470 THR A 120 CG2 REMARK 470 TYR A 126 OH REMARK 470 ALA A 140 CB REMARK 470 ASP A 146 CG OD1 OD2 REMARK 470 LYS A 188 CG CD CE NZ REMARK 470 LEU A 197 CD1 REMARK 470 LYS A 228 CG CD CE NZ REMARK 470 LYS A 239 CG CD CE NZ REMARK 470 MET A 252 CE REMARK 470 THR A 255 CG2 REMARK 470 THR A 263 CG2 REMARK 470 LYS A 266 CG CD CE NZ REMARK 470 THR A 278 CG2 REMARK 470 ARG A 314 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 27 -66.64 -103.82 REMARK 500 VAL A 104 -60.47 -94.90 REMARK 500 ASP A 136 48.39 -148.56 REMARK 500 ASP A 154 76.08 58.65 REMARK 500 ILE A 165 97.53 -66.30 REMARK 500 ASN A 192 -169.01 -125.85 REMARK 500 LEU A 254 59.55 -99.44 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 6G2 A 901 DBREF 5J5T A 13 380 UNP Q8IVH8 M4K3_HUMAN 13 380 SEQADV 5J5T GLY A 11 UNP Q8IVH8 EXPRESSION TAG SEQADV 5J5T SER A 12 UNP Q8IVH8 EXPRESSION TAG SEQADV 5J5T ALA A 170 UNP Q8IVH8 SER 170 ENGINEERED MUTATION SEQRES 1 A 370 GLY SER GLN GLU ASP PHE GLU LEU ILE GLN ARG ILE GLY SEQRES 2 A 370 SER GLY THR TYR GLY ASP VAL TYR LYS ALA ARG ASN VAL SEQRES 3 A 370 ASN THR GLY GLU LEU ALA ALA ILE LYS VAL ILE LYS LEU SEQRES 4 A 370 GLU PRO GLY GLU ASP PHE ALA VAL VAL GLN GLN GLU ILE SEQRES 5 A 370 ILE MET MET LYS ASP CYS LYS HIS PRO ASN ILE VAL ALA SEQRES 6 A 370 TYR PHE GLY SER TYR LEU ARG ARG ASP LYS LEU TRP ILE SEQRES 7 A 370 CYS MET GLU PHE CYS GLY GLY GLY SER LEU GLN ASP ILE SEQRES 8 A 370 TYR HIS VAL THR GLY PRO LEU SER GLU LEU GLN ILE ALA SEQRES 9 A 370 TYR VAL SER ARG GLU THR LEU GLN GLY LEU TYR TYR LEU SEQRES 10 A 370 HIS SER LYS GLY LYS MET HIS ARG ASP ILE LYS GLY ALA SEQRES 11 A 370 ASN ILE LEU LEU TPO ASP ASN GLY HIS VAL LYS LEU ALA SEQRES 12 A 370 ASP PHE GLY VAL SER ALA GLN ILE THR ALA THR ILE ALA SEQRES 13 A 370 LYS ARG LYS ALA PHE ILE GLY THR PRO TYR TRP MET ALA SEQRES 14 A 370 PRO GLU VAL ALA ALA VAL GLU ARG LYS GLY GLY TYR ASN SEQRES 15 A 370 GLN LEU CYS ASP LEU TRP ALA VAL GLY ILE THR ALA ILE SEQRES 16 A 370 GLU LEU ALA GLU LEU GLN PRO PRO MET PHE ASP LEU HIS SEQRES 17 A 370 PRO MET ARG ALA LEU PHE LEU MET THR LYS SER ASN PHE SEQRES 18 A 370 GLN PRO PRO LYS LEU LYS ASP LYS MET LYS TRP SER ASN SEQRES 19 A 370 SER PHE HIS HIS PHE VAL LYS MET ALA LEU THR LYS ASN SEQRES 20 A 370 PRO LYS LYS ARG PRO THR ALA GLU LYS LEU LEU GLN HIS SEQRES 21 A 370 PRO PHE VAL THR GLN HIS LEU THR ARG SER LEU ALA ILE SEQRES 22 A 370 GLU LEU LEU ASP LYS VAL ASN ASN PRO ASP HIS SER THR SEQRES 23 A 370 TYR HIS ASP PHE ASP ASP ASP ASP PRO GLU PRO LEU VAL SEQRES 24 A 370 ALA VAL PRO HIS ARG ILE HIS SER THR SER ARG ASN VAL SEQRES 25 A 370 ARG GLU GLU LYS THR ARG SER GLU ILE THR PHE GLY GLN SEQRES 26 A 370 VAL LYS PHE ASP PRO PRO LEU ARG LYS GLU THR GLU PRO SEQRES 27 A 370 HIS HIS GLU LEU PRO ASP SER ASP GLY PHE LEU ASP SER SEQRES 28 A 370 SER GLU GLU ILE TYR TYR THR ALA ARG SER ASN LEU ASP SEQRES 29 A 370 LEU GLN LEU GLU TYR GLY MODRES 5J5T TPO A 145 THR MODIFIED RESIDUE HET TPO A 145 11 HET 6G2 A 901 26 HETNAM TPO PHOSPHOTHREONINE HETNAM 6G2 5-[2-(PIPERIDIN-4-YL)-1,3-THIAZOL-5-YL]-3-[(PYRIDIN-4- HETNAM 2 6G2 YL)METHOXY]PYRIDIN-2-AMINE HETSYN TPO PHOSPHONOTHREONINE FORMUL 1 TPO C4 H10 N O6 P FORMUL 2 6G2 C19 H21 N5 O S FORMUL 3 HOH *24(H2 O) HELIX 1 AA1 SER A 12 GLU A 14 5 3 HELIX 2 AA2 PHE A 55 ASP A 67 1 13 HELIX 3 AA3 LEU A 98 THR A 105 1 8 HELIX 4 AA4 SER A 109 LYS A 130 1 22 HELIX 5 AA5 PHE A 155 THR A 164 1 10 HELIX 6 AA6 THR A 174 MET A 178 5 5 HELIX 7 AA7 ALA A 179 ARG A 187 1 9 HELIX 8 AA8 LEU A 194 LEU A 210 1 17 HELIX 9 AA9 HIS A 218 LYS A 228 1 11 HELIX 10 AB1 SER A 243 LEU A 254 1 12 HELIX 11 AB2 THR A 263 GLN A 269 1 7 HELIX 12 AB3 HIS A 270 GLN A 275 1 6 HELIX 13 AB4 ARG A 279 ASN A 290 1 12 HELIX 14 AB5 GLU A 306 ALA A 310 5 5 SHEET 1 AA1 5 PHE A 16 SER A 24 0 SHEET 2 AA1 5 ASP A 29 ASN A 35 -1 O LYS A 32 N GLN A 20 SHEET 3 AA1 5 LEU A 41 LYS A 48 -1 O VAL A 46 N ASP A 29 SHEET 4 AA1 5 LYS A 85 MET A 90 -1 O MET A 90 N ALA A 43 SHEET 5 AA1 5 TYR A 76 LEU A 81 -1 N TYR A 80 O TRP A 87 SHEET 1 AA2 3 GLY A 96 SER A 97 0 SHEET 2 AA2 3 ILE A 142 LEU A 144 -1 O LEU A 144 N GLY A 96 SHEET 3 AA2 3 VAL A 150 LEU A 152 -1 O LYS A 151 N LEU A 143 LINK C LEU A 144 N TPO A 145 1555 1555 1.32 LINK C TPO A 145 N ASP A 146 1555 1555 1.31 SITE 1 AC1 11 ILE A 22 GLY A 25 ALA A 43 MET A 90 SITE 2 AC1 11 GLU A 91 PHE A 92 CYS A 93 GLY A 96 SITE 3 AC1 11 ASP A 100 LEU A 143 ASP A 154 CRYST1 92.703 63.324 64.916 90.00 116.04 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010787 0.000000 0.005270 0.00000 SCALE2 0.000000 0.015792 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017145 0.00000